Considerations in Medicine relaunches with BMJ Group to prioritize methodological rigor over novelty in clinical research
Summary
This article introduces the relaunch of Considerations in Medicine with BMJ Group in August 2025. The journal aims to address the imbalance in medical publishing that prioritizes novelty over methodological rigor and global relevance. It will assess submissions primarily on methodological quality rather than potential impact, welcoming validation studies, replication research, context-specific findings, studies from low- and middle-income countries, negative findings, and transparent research protocols. The mission is to complement existing venues by valuing incremental and confirmatory findings alongside novel discoveries.
Source
Key quotes
· 4 pulledConsiderations in Medicine was relaunched with BMJ Group in August 2025 with a new mission and drive, aiming to address this imbalance by providing a venue for research that is methodologically rigorous, contextually grounded and clinically consequential, irrespective of novelty or anticipated citation impact.
We assess submissions primarily on their methodological rigour rather than their potential impact.
We explicitly welcome validation studies, replication research, context-specific findings, methodologically sound observational studies from low- and middle-income countries, studies reporting negative findings and research protocols that articulate transparent and reproducible methodologies.
In doing so, we seek to contribute to a more comprehensive scientific record in which incremental and confirmatory findings are valued with the same rigorous scrutiny as novel findings.
You might also wanna read
Navigating NSAID safety in early pregnancy: Challenges in interpreting congenital malformation risk
This Perspective article by Yuen and Man discusses the challenges of interpreting research on NSAID safety during early pregnancy, particula

Data-driven unification of 72 biomedical publication types and study designs into a hierarchical rubric
This article presents a data-driven approach to unifying 72 biomedical publication types and study designs (PTs) into a single rubric and hi
Studie findet knapp 150.000 fehlerhafte KI-Referenzen in wissenschaftlichen Publikationen
Ein internationales Forschungsteam hat in einer Analyse von 2,5 Millionen wissenschaftlichen Artikeln mit insgesamt 111 Millionen Zitaten kn
Rebalancing power in infectious disease modelling: Toward inclusive and contextual approaches
This article, published in PLOS Global Public Health, argues for rebalancing power dynamics in infectious disease modelling. It critiques th
Unequal Access to New Myasthenia Gravis Therapies Across Europe Highlights Healthcare Disparities
This article examines the growing gap between medical innovation and patient access in the treatment of generalised myasthenia gravis (gMG)
Reuters Digital Health 2026: The End of the Single Decision-Maker in Healthcare Sales
The article reports key insights from the Reuters Digital Health 2026 event in Chicago, focusing on the shift away from traditional healthca

Comments
Sign in to join the conversation.
No comments yet. Be the first.